Skip to main content

Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo Analysis.

Citation
Saunders, D. C., et al. “Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic Β Cells For In Vitro And In Vivo Analysis.”. Cell Metabolism, pp. 745-754.e4.
Center Vanderbilt University
Author Diane C Saunders, Marcela Brissova, Neil Phillips, Shristi Shrestha, John T Walker, Radhika Aramandla, Greg Poffenberger, David K Flaherty, Kevin P Weller, Julie Pelletier, Tracy Cooper, Matt T Goff, John Virostko, Alena Shostak, Danielle Dean, Dale L Greiner, Leonard D Shultz, Nripesh Prasad, Shawn E Levy, Robert H Carnahan, Chunhua Dai, Jean Sévigny, Alvin C Powers
Keywords development, diabetes, glucagon, imaging, insulin, islet, pancreas
Abstract

Identification of cell-surface markers specific to human pancreatic β cells would allow in vivo analysis and imaging. Here we introduce a biomarker, ectonucleoside triphosphate diphosphohydrolase-3 (NTPDase3), that is expressed on the cell surface of essentially all adult human β cells, including those from individuals with type 1 or type 2 diabetes. NTPDase3 is expressed dynamically during postnatal human pancreas development, appearing first in acinar cells at birth, but several months later its expression declines in acinar cells while concurrently emerging in islet β cells. Given its specificity and membrane localization, we utilized an NTPDase3 antibody for purification of live human β cells as confirmed by transcriptional profiling, and, in addition, for in vivo imaging of transplanted human β cells. Thus, NTPDase3 is a cell-surface biomarker of adult human β cells, and the antibody directed to this protein should be a useful new reagent for β cell sorting, in vivo imaging, and targeting.

Year of Publication
2019
Journal
Cell metabolism
Volume
29
Issue
3
Number of Pages
745-754.e4
Date Published
12/2019
ISSN Number
1932-7420
DOI
10.1016/j.cmet.2018.10.007
Alternate Journal
Cell Metab.
PMID
30449685
PMCID
PMC6402969
Download citation